Dr. Sitta Sittampalam is Senior Advisor and Project Manager at NIH’s National Center for Advancing Translational Sciences. He worked for 23 years in drug discovery & development at Eli Lilly and Company, and served 4 years as Deputy Director of the Institute for Advancing Medical Innovations (IAMI), and as a professor of Pharmacology at the University of Kansas Medical Center. He is Editor-in-Chief of the Assay Guidance Manual (NCBI eBook), and serves on grant review panels, the editorial board of the Journal of Biomolecular Sciences and the scientific advisory boards of Science Translational Medicine, Science Exchange, and Stemina Biomarker. His interests are in transformational technologies in drug R&D.
Eric Graban is the founder and CEO of ReclaimRx, LLC, a life sciences start-up company that is developing a novel approach toward protein structural analysis using mass spectrometry. His experience prior to starting Reclaim includes 7 years as a chemist and a manager in the Manufacturing Science and Technology group at Eli Lilly and 6 years as a production and technical services manager for Baxter Pharmaceutical Solution. Eric received his ScB in Biology from Brown University and his MS in Organic Chemistry from Ohio University.